DÄ internationalArchiveReferences

Original article

Adverse Drug Reactions (ADR) and Emergencies

Dtsch Arztebl Int 2018; 115: 251-8. DOI: 10.3238/arztebl.2018.0251

Schurig, A M; Böhme, M; Just, K S; Scholl, C; Dormann, H; Plank-Kiegele, B; Seufferlein, T; Gräff, I; Schwab, M; Stingl, J C

1.Bundesministerium für Gesundheit, Aktionsplan 2016–2019 zur Verbesserung der Arzneimitteltherapiesicherheit in Deutschland. https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/A/Arzneimittelversorgung/Aktionsplan_AMTS_2016–2019.pdf (last accessed on 27. June 2017).
2. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL: National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296: 1858–66 CrossRef MEDLINE
3.van der Hooft CS, Dieleman JP, Siemes C, et al.: Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 2008; 17: 365–71 CrossRef MEDLINE
4.Pirmohamed M, James S, Meakin S, et al.: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15–9 CrossRef MEDLINE MEDLINE PubMed Central
5.Chen YC, Huang HH, Fan JS, et al.: Comparing characteristics of adverse drug events between older and younger adults presenting to a Taiwan emergency department. Medicine (Baltimore) 2015; 94: e547 CrossRef MEDLINE PubMed Central
6.Kim J, Parish AL: Polypharmacy and medication management in older adults. Nurs Clin North Am 2017; 52: 457–68 CrossRef MEDLINE
7.Rottenkolber D, Schmiedl S, Rottenkolber M, et al.: Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf 2011; 20: 626–34 CrossRef MEDLINE
8.Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J: Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285–91 CrossRef MEDLINE
9.Schrappe M: [Patient safety: a topic of the future, the future of the topic]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015; 58: 4–9 CrossRef MEDLINE
10.Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM: Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168: 1890–6 MEDLINE
11.Stang AS, Wingert AS, Hartling L, Plint AC: Adverse events related to emergency department care: a systematic review. PLoS One 2013; 8: e74214 CrossRef MEDLINE PubMed Central
12.Muehlberger N, Schneeweiss S, Hasford J: Adverse drug reaction monitoring—cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf 1997; 6, Suppl 3: 71–7 CrossRef
13.Bouvy JC, de Bruin ML, Koopmanschap MA: Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf 2015; 38: 437–53 CrossRef MEDLINE PubMed Central
14.Meier F, Maas R, Sonst A, et al.: Adverse drug events in patients admitted to an emergency department: an analysis of direct costs. Pharmacoepidemiol Drug Saf 2015; 24: 176–86 CrossRef MEDLINE
15.Schwake L, Wollenschlager I, Stremmel W, Encke J: Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study. Intensive Care Med 2009; 35: 266–74 CrossRef MEDLINE
16.Dormann H, Criegee-Rieck M, Neubert A, et al.: Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf 2003; 26: 353–62 CrossRef MEDLINE
17. Dormann H, Sonst A, Muller F, et al.: Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS). Dtsch Arztebl Int 2013; 110: 213–9 VOLLTEXT
18. EMA: Guideline on good pharmacovigilance practices (GVP), annex I—definitions. www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/05/WC500143294.pdf (last accessed on 6 December 2017).
19.EMA: Good practice guide on recording, coding, reporting and assessment of medication errors. www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/11/WC500196979.pdf (last accessed on 6 December 2017).
20.Huckels-Baumgart S, Manser T: Identifying medication error chains from critical incident reports: a new analytic approach. J Clin Pharmacol 2014; 54: 1188–97 CrossRef MEDLINE
21.The use of the WHO-UMC system for standardised case causality assessment: www.who-umc.org/media/2768/standardised-case-causality-assessment.pdf (last accessed on 12 June 2017).
22.Schumock GT, Thornton JP: Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27: 538 CrossRef
23.Plank-Kiegele B, Burkle T, Muller F, et al.: Data requirements for the correct identification of medication errors and adverse drug events in patients presenting at an emergency department. Methods Inf Med 2017; 56: 276–82 CrossRef MEDLINE
24.Schneeweiss S, Gottler M, Hasford J, et al.: First results from an intensified monitoring system to estimate drug related hospital admissions. Br J Clin Pharmacol 2001; 52: 196–200 CrossRef MEDLINE PubMed Central
25.Davis CP: Emergency department visits: we are not prepared. Am J Emerg Med 2012; 30: 1364–70 CrossRef MEDLINE
26.Krüger-Brand H: Arzneimitteltherapie: Medikationsplan für mehr Sicherheit. Dtsch Arztebl 2015; 112: A-1410.
27. Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H: Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf 2008; 31: 789–98 CrossRef
28.Köberlein-Neu J, Mennemann H, Hamacher S, et al.: Interprofessional medication management in patients with multiple morbidities: a cluster-randomized trial (the WestGem Study). Dtsch Arztebl Int 2016; 113: 741–8 VOLLTEXT
29.Hajjar ER, Cafiero AC, Hanlon JT: Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345–51 CrossRef MEDLINE
30.Moßhammer D, Haumann H, Mörike K, Joos S: Polypharmacy—an upward trend with unpredictable effects. Dtsch Arztebl Int 2016; 113: 627–33 VOLLTEXT
31.Nguyen JK, Fouts MM, Kotabe SE, Lo E: Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006; 4: 36–41 CrossRef MEDLINE
32.Hubbard RE, O‘Mahony MS, Woodhouse KW: Medication prescribing in frail older people. Eur J Clin Pharmacol 2013; 69: 319–26 CrossRef MEDLINE
33.Nickel CH, Ruedinger JM, Messmer AS, et al.: Drug-related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med 2013; 21: 15 CrossRef MEDLINE PubMed Central
34.Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R: Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging 2012; 29: 359–76 CrossRef MEDLINE
35.Young J, Inouye SK: Delirium in older people. BMJ 2007; 334: 842–6 CrossRef MEDLINE PubMed Central